Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In this nonrandomized trial, sitagliptin in combination with tacrolimus and sirolimus resulted in a low incidence of grade II to IV Acute Graft-Versus-Host Disease (acute GVHD) by day 100 after myeloablative allogeneic hematopoietic stem-cell transplantation
Farag et al. 2021 N Engl J Med 384: 11-19…